Circulating levels of monocyte chemoattractant protein-1 as a potential measure of biological age in mice and frailty in humans

Matthew J. Yousefzadeh, Marissa J. Schafer, Nicole Noren Hooten, Elizabeth J. Atkinson, Michele K. Evans, Darren J. Baker, Ellen K. Quarles, Paul D. Robbins, Warren C. Ladiges, Nathan K. LeBrasseur, Laura J. Niedernhofer

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A serum biomarker of biological versus chronological age would have significant impact on clinical care. It could be used to identify individuals at risk of early-onset frailty or the multimorbidities associated with old age. It may also serve as a surrogate endpoint in clinical trials targeting mechanisms of aging. Here, we identified MCP-1/CCL2, a chemokine responsible for recruiting monocytes, as a potential biomarker of biological age. Circulating monocyte chemoattractant protein-1 (MCP-1) levels increased in an age-dependent manner in wild-type (WT) mice. That age-dependent increase was accelerated in Ercc1 −/Δ and Bubr1 H/H mouse models of progeria. Genetic and pharmacologic interventions that slow aging of Ercc1 −/Δ and WT mice lowered serum MCP-1 levels significantly. Finally, in elderly humans with aortic stenosis, MCP-1 levels were significantly higher in frail individuals compared to nonfrail. These data support the conclusion that MCP-1 can be used as a measure of mammalian biological age that is responsive to interventions that extend healthy aging.

Original languageEnglish (US)
Article numbere12706
JournalAging cell
Volume17
Issue number2
DOIs
StatePublished - Apr 2018

Fingerprint

Chemokine CCL2
Biomarkers
Progeria
Genetic Engineering
Aortic Valve Stenosis
Comorbidity
Blood Proteins
Monocytes
Clinical Trials
Serum

Keywords

  • CCL2
  • biological age
  • biomarkers of aging
  • chemokine
  • geropathology
  • monocyte chemoattractant protein-1

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural

Cite this

Circulating levels of monocyte chemoattractant protein-1 as a potential measure of biological age in mice and frailty in humans. / Yousefzadeh, Matthew J.; Schafer, Marissa J.; Noren Hooten, Nicole; Atkinson, Elizabeth J.; Evans, Michele K.; Baker, Darren J.; Quarles, Ellen K.; Robbins, Paul D.; Ladiges, Warren C.; LeBrasseur, Nathan K.; Niedernhofer, Laura J.

In: Aging cell, Vol. 17, No. 2, e12706, 04.2018.

Research output: Contribution to journalArticle

Yousefzadeh, Matthew J. ; Schafer, Marissa J. ; Noren Hooten, Nicole ; Atkinson, Elizabeth J. ; Evans, Michele K. ; Baker, Darren J. ; Quarles, Ellen K. ; Robbins, Paul D. ; Ladiges, Warren C. ; LeBrasseur, Nathan K. ; Niedernhofer, Laura J. / Circulating levels of monocyte chemoattractant protein-1 as a potential measure of biological age in mice and frailty in humans. In: Aging cell. 2018 ; Vol. 17, No. 2.
@article{c950868b212c4f5b98ba767f76cd28be,
title = "Circulating levels of monocyte chemoattractant protein-1 as a potential measure of biological age in mice and frailty in humans",
abstract = "A serum biomarker of biological versus chronological age would have significant impact on clinical care. It could be used to identify individuals at risk of early-onset frailty or the multimorbidities associated with old age. It may also serve as a surrogate endpoint in clinical trials targeting mechanisms of aging. Here, we identified MCP-1/CCL2, a chemokine responsible for recruiting monocytes, as a potential biomarker of biological age. Circulating monocyte chemoattractant protein-1 (MCP-1) levels increased in an age-dependent manner in wild-type (WT) mice. That age-dependent increase was accelerated in Ercc1 −/Δ and Bubr1 H/H mouse models of progeria. Genetic and pharmacologic interventions that slow aging of Ercc1 −/Δ and WT mice lowered serum MCP-1 levels significantly. Finally, in elderly humans with aortic stenosis, MCP-1 levels were significantly higher in frail individuals compared to nonfrail. These data support the conclusion that MCP-1 can be used as a measure of mammalian biological age that is responsive to interventions that extend healthy aging.",
keywords = "CCL2, biological age, biomarkers of aging, chemokine, geropathology, monocyte chemoattractant protein-1",
author = "Yousefzadeh, {Matthew J.} and Schafer, {Marissa J.} and {Noren Hooten}, Nicole and Atkinson, {Elizabeth J.} and Evans, {Michele K.} and Baker, {Darren J.} and Quarles, {Ellen K.} and Robbins, {Paul D.} and Ladiges, {Warren C.} and LeBrasseur, {Nathan K.} and Niedernhofer, {Laura J.}",
year = "2018",
month = "4",
doi = "10.1111/acel.12706",
language = "English (US)",
volume = "17",
journal = "Aging Cell",
issn = "1474-9718",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Circulating levels of monocyte chemoattractant protein-1 as a potential measure of biological age in mice and frailty in humans

AU - Yousefzadeh, Matthew J.

AU - Schafer, Marissa J.

AU - Noren Hooten, Nicole

AU - Atkinson, Elizabeth J.

AU - Evans, Michele K.

AU - Baker, Darren J.

AU - Quarles, Ellen K.

AU - Robbins, Paul D.

AU - Ladiges, Warren C.

AU - LeBrasseur, Nathan K.

AU - Niedernhofer, Laura J.

PY - 2018/4

Y1 - 2018/4

N2 - A serum biomarker of biological versus chronological age would have significant impact on clinical care. It could be used to identify individuals at risk of early-onset frailty or the multimorbidities associated with old age. It may also serve as a surrogate endpoint in clinical trials targeting mechanisms of aging. Here, we identified MCP-1/CCL2, a chemokine responsible for recruiting monocytes, as a potential biomarker of biological age. Circulating monocyte chemoattractant protein-1 (MCP-1) levels increased in an age-dependent manner in wild-type (WT) mice. That age-dependent increase was accelerated in Ercc1 −/Δ and Bubr1 H/H mouse models of progeria. Genetic and pharmacologic interventions that slow aging of Ercc1 −/Δ and WT mice lowered serum MCP-1 levels significantly. Finally, in elderly humans with aortic stenosis, MCP-1 levels were significantly higher in frail individuals compared to nonfrail. These data support the conclusion that MCP-1 can be used as a measure of mammalian biological age that is responsive to interventions that extend healthy aging.

AB - A serum biomarker of biological versus chronological age would have significant impact on clinical care. It could be used to identify individuals at risk of early-onset frailty or the multimorbidities associated with old age. It may also serve as a surrogate endpoint in clinical trials targeting mechanisms of aging. Here, we identified MCP-1/CCL2, a chemokine responsible for recruiting monocytes, as a potential biomarker of biological age. Circulating monocyte chemoattractant protein-1 (MCP-1) levels increased in an age-dependent manner in wild-type (WT) mice. That age-dependent increase was accelerated in Ercc1 −/Δ and Bubr1 H/H mouse models of progeria. Genetic and pharmacologic interventions that slow aging of Ercc1 −/Δ and WT mice lowered serum MCP-1 levels significantly. Finally, in elderly humans with aortic stenosis, MCP-1 levels were significantly higher in frail individuals compared to nonfrail. These data support the conclusion that MCP-1 can be used as a measure of mammalian biological age that is responsive to interventions that extend healthy aging.

KW - CCL2

KW - biological age

KW - biomarkers of aging

KW - chemokine

KW - geropathology

KW - monocyte chemoattractant protein-1

UR - http://www.scopus.com/inward/record.url?scp=85039725268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039725268&partnerID=8YFLogxK

U2 - 10.1111/acel.12706

DO - 10.1111/acel.12706

M3 - Article

C2 - 29290100

AN - SCOPUS:85039725268

VL - 17

JO - Aging Cell

JF - Aging Cell

SN - 1474-9718

IS - 2

M1 - e12706

ER -